Nicholas Investment Partners, LP

Position in CYTK — Cytokinetics Inc

CIK 1389574 RANCHO SANTA FE, CA

Position in CYTK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$17,810,758

+$13,207,275 QoQ

Shares Held

209,071

+199.3% QoQ

Ownership

0.150%

of shares outstanding

% of Portfolio

1.14%

of 13F equity value

Holder Rank

#96

of 478 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nicholas Investment Partners, LP holds $271,971,066 across 20 Biotechnology names. CYTK ranks #8 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	244,594	$45,807,564
2	AXSM	Axsome Therapeutics, Inc.	98,974	$24,225,865
3	XENE	Xenon Pharmaceuticals Inc.	395,844	$23,893,143
4	BBIO	BridgeBio Pharma, Inc.	311,494	$23,200,073
5	MIRM	Mirum Pharmaceuticals, Inc.	172,695	$20,217,403
6	ELVN	Enliven Therapeutics, Inc.	391,529	$19,870,096
7	DNTH	Dianthus Therapeutics, Inc. /DE/	186,769	$18,206,242
8	CYTK	Cytokinetics Inc This page	209,071	$17,810,758

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,810,758	209,071	+199.3%	Shares	Sole	2026-08-14
2026-03-31	$4,603,483	69,845	-0.6%	Shares	Sole	2026-05-15
2025-12-31	$4,463,049	70,240	+13.1%	Shares	Sole	2026-02-13
2025-09-30	$3,413,950	62,117	+462.2%	Shares	Sole	2025-11-14
2024-12-31	$519,744	11,049	0.0%	Shares	Sole	2025-02-14
2024-09-30	$583,387	11,049	-89.2%	Shares	Sole	2024-11-12
2023-12-31	$8,563,736	102,572	-89.1%	Shares	Sole	2024-02-08
2023-09-30	$27,755,356	942,137	+38.0%	Shares	Sole	2023-11-13
2023-06-30	$22,275,121	682,867	+11.8%	Shares	Sole	2023-08-10
2023-03-31	$21,500,738	610,990	+10.9%	Shares	Sole	2023-05-12
2022-12-31	$25,252,684	551,128	+16.6%	Shares	Sole	2023-02-10
2022-09-30	$22,909,049	472,839	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.